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Objectives
! Review the epidemiology and trends of diabetes
! Discuss the pathophysiology of diabetes
! Delineate treatment strategies including lifestyle modification
and medications

Epidemiology
! 11.3% of those over the age of 20 living with DM2 in the US1
! World Health Organization estimates 7th leading cause of
death by 20302
! More than $300 billion spent on diabetes-related medical
costs in 20123

1.Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general
information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and
Human Services, Centers for Disease Control and Prevention, 2011.
2.World Health Organization. Diabetes Fact Sheet No. 312. Reviewed October 2013.
www.who.int/mediacentre/factsheets/fs312/en/. Accessed May 9, 2014.
3.American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care
2013;36:1033-1046.

CDC Fact Sheet

DM2 Epidemiology
! 90% of those with diabetes in the US, Canada, and Europe
have type 2 diabetes

County-level Estimates of Diagnosed Diabetes among Adults aged ≥ 20 years:
United States 2004

County-level Estimates of Diagnosed Diabetes among Adults aged ≥ 20 years:
United States 2011

! Number of people with diabetes has more than doubled in
the past 20 years
! Concerning is the number of new diagnoses in children and
adolescents
! Need to work on prevention with focus on social and
environmental factors

What is diabetes?

Definition of Diabetes
! Group of diseases resulting in elevated blood glucose levels
! Involves insufficient insulin or decreased response to insulin
resulting in elevated blood glucose
! Glucose is the energy source for the cells

www.mayoclinic.org/diseases-conditions/diabetes/basics/definitions

Types of Diabetes
! Type 1 Diabetes (DM1)
! Type 2 Diabetes (DM2)
! Prediabetes
! Gestational Diabetes

DM1
! Autoimmune destruction of
insulin producing beta cells in
pancreas
! Insulin dependent
! Typically childhood onset
! 5 – 10% of diabetes
worldwide
dtc.ucsf.edu

http://www.trumanlibrary.org/histday/insulin/diabetes-before-insulin.html

Nobel Prize in 1923

Insulin
! Hormone that regulates the amount
of glucose in the blood
! Produced by beta cells in pancreas
! Beta cells release insulin with each
meal to help the body use or store
glucose

www2.massgeneral.org

Prediabetes
! Impaired fasting glucose or impaired glucose tolerance
! Increased risk for developing DM2
! Annual screening for diabetes recommended
! Intensive lifestyle modifications recommended

DM2
! Inadequate insulin production OR
! Insulin resistance OR
! Inadequate insulin production AND insulin resistance
! Linked to obesity
! Increased risk if African, Asian, Native American, Latino, or
Pacific Islander

Gestational DM
! Increased risk if overweight or obese prior to pregnancy
! Affects 2 – 10% of women during pregnancy
! Increases risk of DM2

Summary
! Diabetes increasing in prevalence
! 4 Types: DM1, DM2, Prediabetes, and Gestational Diabetes
! Increased prevalence linked to obesity and environmental
factors

Questions?

Pathophysiology

Pathophysiology
1. Impaired Insulin Secretion
2. Hyperglycemia
3. Insulin Resistance

Metabolic Defects
! Decreased glucose transport and utilization at the level of the
muscle and adipose tissue
! Increased glucose production by the liver
! Decreased insulin secretion by the pancreas

What organs are involved?
! Pancreas: beta cells secrete insulin and amylin, alpha cells
secrete glucagon
! GI Tract: secrete GLP-1 to signal beta cells to increase
insulin and alpha cells to decrease glucagon
! Liver: stores glucose as glycogen, supplies glucose via
glyconeogenesis and gluconeogenesis
! Muscles and adipose tissue: remove glucose from the blood
! Adrenal glands: secrete epinephrine and cortisol

Insulin Secretion
! From beta cells in pancreas
! Decreases over time in DM2
! May be exacerbated by hyperglycemia

Alpha and Beta Cells in Pancreas

dtc.ucsf.edu

Insulin Resistance
! Likely genetic component
! Exacerbated by inflammatory particles secreted by adipose
tissue (leptin adiponectin, tumor necrosis factor alpha, and
resistin)

dtc.ucsf.edu

Insulin and Glucagon

Glucagon
! Produced by alpha cells in pancreas
! Serves as counterbalance to insulin
! Signal liver to initiate glyconeogenesis
! In DM, glucagon levels rise inappropriately after eating

Fasting State

dtc.ucsf.edu

GLP-1
! Released from gut
! Signal beta cells to
increase insulin and
decrease glucagon

Epinephrine and Cortisol

dtc.ucsf.edu

Fasting State

dtc.ucsf.edu

GLP-1
! Released from gut
! Signal beta cells to
increase insulin and
decrease glucagon

Epinephrine and Cortisol

dtc.ucsf.edu

What organs are involved?
! Pancreas: beta cells secrete insulin and amylin, alpha cells
secrete glucagon
! GI Tract: secrete GLP-1 to signal beta cells to increase
insulin and alpha cells to decrease glucagon
! Liver: stores glucose as glycogen, supplies glucose via
glyconeogenesis and gluconeogenesis
! Muscles and adipose tissue: remove glucose from the blood
! Adrenal glands: secrete epineprhine and cortisol

Genetic Causes
! Lifetime risk of DM2 is 5-10 times higher in first-degree
relatives
! Increased prevalence in certain ethnic groups, including
people of Hispanic, African, and Asian decent

Environmental Causes
! Food sources
! Activity levels
! Built environment

! Need to recognize implications of built, food, school, and
work environments
! Greater impact on groups with lower socioeconomic status

Summary
! Diabetes is the resultant hyperglycemia from inadequate
insulin secretion, insulin resistance, or both
! It is progressive, with continual beta cell decline over time
! Genetic and environmental factors also play a role

Questions?

TREATMENT
STRATEGIES

Goal
! Approach normoglycemia for most patients to decrease risk
of microvascular and macrovascular complications

Treatment Strategies
1. Lifestyle modifications: weight loss, dietary changes,
increased physical activity
2. Self-monitoring
3. Medications: oral medications, injectable non-insulin
medications, insulin
4. Screening for and preventing complications

! Tailored approach to treatment based on age, comorbidities,
and availability of resources

Depiction of the elements of decision making used to determine appropriate efforts to
achieve glycemic targets.

Inzucchi S E et al. Dia Care 2012;35:1364-1379

Copyright © 2011 American Diabetes Association, Inc.

Lifestyle Modifications
! Low carbohydrate diets
! Increased physical activity
! Weight loss
! Bariatric surgery

Bariatric surgery
! Patients followed for 15 years after surgery
! Associated with increased likelihood of long-term remission
and decreased rates of microvascular and macrovascular
complications

Sjostrom L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and
with microvascular and macrovascular complications. JAMA 2014;311(22):2297-2304.

Diabetes Super Foods
! Beans
! Green leafy vegetables
! Sweet potatoes
! Berries
! Fish rich in omega 3 Fatty acids
! Fat-free milk and yogurt
! Whole grains
! Tomatoes
! Citrus fruits

County-level Estimates of Leisure-time Physical Inactivity among Adults aged ≥ 20 years:
United States 2004

County-level Estimates of Leisure-time Physical Inactivity among Adults aged ≥ 20 years:
United States 2011

DM Management
! Requires patient-activation and patient-clinician partnerships
! Gradual decline of beta cell function over time warrants
changes to the care plan

Self-management
! Dietary changes
! Monitoring and recording blood glucose
! Keeping a log book of glucose readings
! Regular foot checks
! Laboratory tests

Hemoglobin A1c
! Glucose attaches to hemoglobin -> glycosylated hemoglobin
! Provides estimate of average glucose over the past 3 months
! May not be accurate if hemoglobin mutation

Medications

Source: 2007–2009 National Health Interview Survey.

Metformin
! First line oral agent
! Decreases hepatic glucose production
! Insulin sensitizer
! Shown to decrease mortality

Sulfonylureas
! Bind to component of ATP-dependent potassium channel in
pancreatic beta cell (sulfonylurea 1 receptor)
! Stimulate insulin secretion from the pancreas
! Include glipizide, glyburide, gliclazide, and glimepiride

Incretin Based Therapies (DPP-4
Inhibitors, GLP-1 Agonist)
! DPP-4 inhibitors result in increased
GLP-1
! GLP-1 is produced by small
intestines in response to food
! GLP-1 Agonists bind to GLP-1
receptors and stimulate insulin
release
! Both mechanisms achieve same
goal of glucose-dependent insulin
release from pancreas

Thiazolidinediones
! Increase insulin sensitivity to remove glucose from the blood
stream
! Act on muscles, adipose tissue, and the liver to increase
glucose use and decrease glucose production
! Mechanism not fully understood
! Bind to peroxisome proliferator-activated receptors to
regulate gene expression

Insulin
! Secreted with meals and in a pulsatile
manner for basal level
! ~50% of insulin secretion is basal with the
remaining being secreted around meals

Types of Insulin
! Rapid-acting
! Regular or Short-acting
! Intermediate-acting
! Long-acting

Modes of Insulin Administration
! Injection from insulin in bottle
! Injection from insulin pen
! Insulin pumps
! More flexibility in dosing
! Fewer highs and lows

Why is insulin not a pill?
! Insulin would be inactivated in the digestive system
! Needs to be injected to enter bloodstream

Summary
! Most effective treatment strategies combine lifestyle
changes, self-care, medications, and prevention of
complications
! Most patients will eventually require insulin given progressive
nature of the disease

How has treatment changed in the
21st century?
! Creation of additional oral medications
! More sophisticated insulin pumps
! Increased use of bariatric surgery
! Technology support for self management (telehealth, patient
portals)

Innovations in Technology

Glooko.com

More to come"
! Genetic testing to identify predisposition and which
medications will be most effective
! New oral and injectable medications
! Health policy for prevention
! More pancreas transplants?

Institute for Healthcare
Improvement Triple Aim

http://www.ihi.org/Engage/Initiatives/TripleAim/Pages/default.aspx
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